Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Public Storage — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.06 (market cap $2.86B), while Public Storage trades at $290.77 (market cap $53.89B). The key difference: Public Storage is far larger — about 18.8× Dyne Therapeutics Inc. Common Stock's market cap, and Public Storage pays a 4.16% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Public Storage for 130 Days on average.
| DYN | PSA | |
|---|---|---|
Market Cap | $2.86B | $53.89B |
Volume | 3,341,579 | 947,047 |
Sector | Health | Real Estate |
52-Week High | $26.78 | $330.47 |
52-Week Low | $14.60 | $258.44 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $2.18B | $68.16B |
Dividend Yield | — | 4.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Public Storage (PSA) trades at $288.76, showing minimal daily movement (-0.04%) with neutral technical indicators. The REIT maintains strong fundamentals including a 41.8% net income margin and consistent earnings beats, though valuation metrics appear elevated with a P/E of 27.52. Recent developments include the completion of the Public Storage Canada acquisition and a $400 million Canadian debt offering, positioning for strategic growth.
PSA presents a mixed outlook with analyst consensus pointing to 14% upside to the $328.33 price target, though the majority (64%) recommend Hold. Key risks include REIT sector sensitivity to interest rates and competitive pressures, while the 4.05% dividend yield provides income stability. The stock's premium valuation requires sustained operational execution to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
